Tezepelumab manufacturers
- Tezepelumab
-
- $263.00
-
2026-07-31
- CAS:1572943-04-4
- Purity: 95.00%
- Supply Ability: 10g
|
| | Tezepelumab Basic information |
| Product Name: | Tezepelumab | | Synonyms: | Tezepelumab;Research Grade Tezepelumab(DHJ36101);Tezepelumab-ekko|||MEDI 19929|||AMG 157;Research Grade Tezepelumab;Tezepelumab (anti-TSLP) | | CAS: | 1572943-04-4 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![Tezepelumab Structure]() |
| | Tezepelumab Chemical Properties |
| form | Liquid | | color | Colorless to light yellow |
| | Tezepelumab Usage And Synthesis |
| Uses | Tezepelumab (anti-TSLP) is human monoclonal antibody (IgG2λ) that binds specifically to TSLP, blocking it from interacting with its heterodimeric receptor. Tezepelumab can be used for the research of severe, uncontrolled asthma[1]. | | References | [1] Menzies-Gow A, et, al. Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma. N Engl J Med. 2021 May 13;384(19):1800-1809. DOI:10.1056/NEJMoa2034975 |
| | Tezepelumab Preparation Products And Raw materials |
|